Fundamentals of Transplant and Cellular Therapy- Day 2 - CRS/ICANS -Enduring Material - Credit offering period June 16, 2026 - December 31, 2026

Caitlin Brown BSN, RN and Marcia Almiron-Wolbert MSN, RN, OCN
* Scientific basis/Immuno-effector cells

 

References:

https://nci-media.cancer.gov/pdq/media/images/774647.jpg

https://www.aoncology.com/education-posts/understanding-bispecific-therapies-bite/

Target Audience

Physicians, nurses, pharmacists, and allied health care professionals who practice in hematological-medical units, skilled nursing facilities, home care, hospice, radiation oncology, surgical oncology, and/or cellular transplant. 

Learning Objectives

Recognize symptoms of Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)

Demonstrate effective assessment skills, maintain thorough documentation, and provide comprehensive care for patients experiencing CRS and ICANS

Course summary

Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
Course opens: 
06/16/2026
Course expires: 
12/31/2026
Cost:
$0.00
Rating: 
0

Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Allegheny General Hospital designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

Available Credit

  • 0.50 AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.